September 2006

|
Volume 18 Issue 9
There are three classic techniques described for reimplantation of coronary arteries after repair of the ascending thoracic aorta.1–4 The original Bentall procedure was described in 1968 and is considered the standard technique .5 The Cabrol techniqu…
Fulminant myocarditis (FM) is an uncommon but potentially fatal condition characterized by widespread myocardial inflammation leading to severe decompensated heart failure.1 Rapidly progressive biventricular dysfunction or malignant arrhythmias can p…
**i*There are three classic techniques described for reimplantation of coronary arteries after repair of the ascending thoracic aorta.1–4 The original Bentall procedure was described in 1968 and is considered the standard technique.5 The Cabrol techn…
Is There a Need for a Technology that Will Promote Positive Remodeling and Mild Plaque Increase? “Favorable vessel remodeling observed in this study is consistent with the result of the previous gamma radiation study noted above,1 as well as those…
Compared with bare metal stents (BMS), drug-eluting stents (DES) significantly reduce the risk of restenosis and the subsequent need for revascularization.1 Stent thrombosis remains a serious complication with either BMS or DES, with an incidence of…
Coronary arteries originating from a single coronary ostium (CO) in the aorta, in the absence of congenital heart disease (CHD), are rare.1 In several large series, the incidence ranged from 0.024% to 0.066%.2–4 In 1979, Lipton et al proposed a class…
Case Report. A 51-year-old male was referred to our center because a fractured 9 Fr sheath, 7 cm long, inserted in the right vena jugularis interna migrated to the right ventricle. Both ends of the broken sheath impinged against the tricuspid chordal…
Reported success rates of percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) range from approximately 60–75%,1–3 and are much lower when compared with PCI of nontotal occlusions.4,5 When combined with specialized equipment, s…
Drug-eluting stent (DES) implantation has been shown to considerably reduce the occurrence of restenosis compared to other modalities of percutaneous coronary intervention (PCI) such as plain old balloon angioplasty (POBA), bare metal stent (BMS) imp…
The first percutaneous transluminal coronary angioplasty (PTCA) in humans was performed by Dr. Andreas Gruentzig in 1974.1 Since then, major evolutions in PTCA have resulted in over 1,000 angioplasty procedures in the registry by 1980. The next decad…